logo_web
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet
✕
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet

The Andalusian Regional Government and Farmaindustria will promote R&D&I in health with a special focus on the promotion of clinical trials.

In a press release, the Andalusian Regional Government highlights the joint commitment of both entities to continue advancing in the promotion of R&D&I, following the meeting of the Secretary General for Public Health and Health Research, Development and Innovation of the Regional Ministry of Health and Consumer Affairs, Isaac Túnez, with the Governing Council of the employers’ association of pharmaceutical companies based in Spain.

El director general de Farmaindustria, Juan Yermo; el secretario general de Salud Pública e I+D+i en Salud de la Consejería de Salud y Consumo de la Junta de Andalucía, Isaac Túnez, y el presidente de Farmaindustria, Jesús Ponce.

Farmaindustria.es

In a press release, the Andalusian Regional Government has shown its collaboration with Farmaindustria in the promotion of R&D&I in health, with special emphasis on clinical trials.

Following the meeting between the Secretary General for Public Health and Health Research, Development and Innovation of the Regional Ministry of Health and Consumer Affairs, Isaac Túnez, and the Governing Council of the employers’ association of pharmaceutical companies based in Spain, the regional government has issued a press release detailing the joint work, which can be read in full here.

It highlights lines of collaboration such as the recent pilot study for remote monitoring in clinical trials carried out in Andalusian Health Service (SAS) centres, in which several health centres and nine companies associated with Farmaindustria are participating.

In addition to this pilot project, the Regional Ministry of Health and Consumer Affairs has collaborated in the project of the Guide of good practice recommendations for the promotion of clinical research in Primary Care, launched by the Association and in which representatives of the Progreso y Salud Foundation and researchers from the Community have participated. This project is in line with Andalusia’s strategy to promote clinical trials at this level of care.

In the field of dissemination, Malaga – through the Biomedical Research Institute of Malaga, Ibima – has already held five editions of the Farmaindustria programme “Bringing science to schools”, which seeks to disseminate the value of drug R&D among young students.

Another area of collaboration is the Farma-Biotech Cooperation Programme, with which Andalusia collaborates through the Granada Health Technology Park and which seeks to promote the connection of pre-clinical researchers with pharmaceutical companies.

Related entries

10 December, 2025

The first fast track for multinational clinical trials in Europe will start in January 2026 and will help strengthen European competitiveness in this area.


Leer más
2 December, 2025

Spain takes a key step forward with the new Regional Map and Observatory for Clinical Research in Primary Care


Leer más
19 November, 2025

Adaptive clinical trials, a key element in transforming vaccine development globally


Leer más

Recent Posts

  • The first fast track for multinational clinical trials in Europe will start in January 2026 and will help strengthen European competitiveness in this area.
  • Spain takes a key step forward with the new Regional Map and Observatory for Clinical Research in Primary Care
  • Adaptive clinical trials, a key element in transforming vaccine development globally
  • ‘Bringing science closer to schools’: a decade of training young people in clinical research and inspiring vocations
  • “Distefar, highly conscious of the environment, welcomes and echoes the environmental transformation that the pharmaceutical industry is undergoing towards sustainability.”

Contacta con nosotros


Tfno: +34 955.77.67.67
Fax: +34 955.77.65.56
info@distefar.net


Distefar del Sur
Sede Central

Distefar del Sur S.L.
Av. Umbrete, 58,
41110 Bollullos de la Mitación, Sevilla

Sede Madrid

Calle de Zurbano, 45, 28010 Madrid

CENTRAL

Pol. PIBO. Avda. de Gines, 14
+34 955 776 767 /+34 692 454 913
41110 Bollullos de la Mitación (Sevilla)

MADRID DELEGATION

+34 674 575 115
28010 Madrid

Links of interest

  • Legal warning
  • Privacy policy
  • Cookies policy
  • Contact

© 2025 Distefar del Sur SL. All rights reserved. agencianodo.com

  • No translations available for this page
  • Contact
  • Private Zone
  • English

    [recaptcha]

    In accordance with the provisions of Regulation (EU) 2016/679 and Organic Law 3/2018 regarding Data Protection, we inform you that the data you provide in this form will be incorporated into a file owned by DISTEFAR DEL SUR, SL domiciled in the C / Umbrete 58, (Pol. Ind. Pibo), 41110 of Bollullos de la Mitación (Seville), in order to manage your request.

    In this regard, and if you wish to exercise your rights of access, rectification, cancellation, opposition, portability and limitation, please send a written communication to DISTEFAR DEL SUR, SL, to the address indicated above or to info@distefar.com, attaching copy of your National Identity Document or equivalent identification document.

    Basic information about Data Protection

     Epigraph

    Basic information Data Protection

    Responsable

    DISTEFAR DEL SUR, S.L.

    Purpose

    Process your inquiry / request
    Detailed information on Data Protection

    Legitimation

    Consent
    Detailed information on Data Protection

    Recipients

    It is not expected to carry out data communications to third parties, except legal obligation
    Transfers of data to third countries outside the European Union will not be carried out
    Detailed information on Data Protection

    Rights

    You have the right of access, rectification, deletion, portability of your data, as well as limitation or opposition to your treatment, as detailed in Detailed information on Data Protection

    Additional Information

    You can consult the additional and detailed information on data protection by clicking here Detailed information on Data Protection

    All the data requested / The fields marked with * in the form are mandatory, if not filled in DISTEFAR DEL SUR, S.L. will not be able to meet your request.